Cargando…

“Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials

Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants’ full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakada, Haruka, Yoshida, Sachie, Muto, Kaori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350979/
https://www.ncbi.nlm.nih.gov/pubmed/30695047
http://dx.doi.org/10.1371/journal.pone.0211338
_version_ 1783390522507788288
author Nakada, Haruka
Yoshida, Sachie
Muto, Kaori
author_facet Nakada, Haruka
Yoshida, Sachie
Muto, Kaori
author_sort Nakada, Haruka
collection PubMed
description Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants’ full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision of whether to give consent. The objective of this study, therefore, is to analyze patients’ decision-making process when participating in clinical trials. We conduct an internet survey (n = 2,045) and interview data analysis (n = 40) with patients and categorize respondents into three types of participants: active, passive, and non-participation. Our results show that patients often make informal and quick decisions before medical staff provide them with relevant information during the informed consent process. For example, 55.9% of patients received initial information on clinical trials from an online article or web advertising, and 54.5% consulted no one about whether to participate in the clinical trial before making a decision. Only 20.7% of respondents subjectively spent time making the decision whether to participate; 43.0% of patients who said that they “spent time” coming to a decision took four or more days to reach a decision, while 8.3% of people who “did not spend time” making a decision took this among of time. Based on these results, we were able to break patients’ decision-making process into four steps: first contact, informal decision making, relevant information, and formal decision making. Our results show that patients are most likely to make a decision based on the first information they receive on the clinical trial, whatever the source. To this end, having a list of questions for potential participants to ask researchers would be useful in helping better collecting information of clinical trials. In addition, research teams should give patients more than four days to decide between providing them with relevant information and obtaining written consent, even if the patient seems to make a quick decision.
format Online
Article
Text
id pubmed-6350979
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63509792019-02-15 “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials Nakada, Haruka Yoshida, Sachie Muto, Kaori PLoS One Research Article Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants’ full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision of whether to give consent. The objective of this study, therefore, is to analyze patients’ decision-making process when participating in clinical trials. We conduct an internet survey (n = 2,045) and interview data analysis (n = 40) with patients and categorize respondents into three types of participants: active, passive, and non-participation. Our results show that patients often make informal and quick decisions before medical staff provide them with relevant information during the informed consent process. For example, 55.9% of patients received initial information on clinical trials from an online article or web advertising, and 54.5% consulted no one about whether to participate in the clinical trial before making a decision. Only 20.7% of respondents subjectively spent time making the decision whether to participate; 43.0% of patients who said that they “spent time” coming to a decision took four or more days to reach a decision, while 8.3% of people who “did not spend time” making a decision took this among of time. Based on these results, we were able to break patients’ decision-making process into four steps: first contact, informal decision making, relevant information, and formal decision making. Our results show that patients are most likely to make a decision based on the first information they receive on the clinical trial, whatever the source. To this end, having a list of questions for potential participants to ask researchers would be useful in helping better collecting information of clinical trials. In addition, research teams should give patients more than four days to decide between providing them with relevant information and obtaining written consent, even if the patient seems to make a quick decision. Public Library of Science 2019-01-29 /pmc/articles/PMC6350979/ /pubmed/30695047 http://dx.doi.org/10.1371/journal.pone.0211338 Text en © 2019 Nakada et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nakada, Haruka
Yoshida, Sachie
Muto, Kaori
“Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials
title “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials
title_full “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials
title_fullStr “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials
title_full_unstemmed “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials
title_short “Tell me what you suggest, and let’s do that, doctor”: Patient deliberation time during informal decision-making in clinical trials
title_sort “tell me what you suggest, and let’s do that, doctor”: patient deliberation time during informal decision-making in clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350979/
https://www.ncbi.nlm.nih.gov/pubmed/30695047
http://dx.doi.org/10.1371/journal.pone.0211338
work_keys_str_mv AT nakadaharuka tellmewhatyousuggestandletsdothatdoctorpatientdeliberationtimeduringinformaldecisionmakinginclinicaltrials
AT yoshidasachie tellmewhatyousuggestandletsdothatdoctorpatientdeliberationtimeduringinformaldecisionmakinginclinicaltrials
AT mutokaori tellmewhatyousuggestandletsdothatdoctorpatientdeliberationtimeduringinformaldecisionmakinginclinicaltrials